Cash Flow from Operating Activities: A company's cash flows from operations.
Dermata Therapeutics, Inc. (DRMA) had Cash Flow from Operating Activities of $-2.48M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.85M |
|
-- |
|
-- |
|
$1.93M |
|
$-1.93M |
|
$0.08M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.93M |
|
$-1.93M |
|
3.86M |
|
3.86M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$7.47M |
|
-- |
|
-- |
|
$7.47M |
|
$1.05M |
|
-- |
|
-- |
|
$1.05M |
|
$6.41M |
|
$6.41M |
|
$6.41M |
|
4.02M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-2.48M |
-- |
|
$1.90M |
|
$7.52M |
|
$6.95M |
|
$-0.58M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.81% |
|
-28.81% |
|
-24.75% |
|
-28.81% |
|
$1.59 |
|
$-0.64 |
|
$-0.64 |
|